GSK acquires respiratory candidate

February 4, 2010
Research and Development Apeiron, GlaxoSmithKline, respiratory

GlaxoSmithKline has acquired exclusive rights to a biotherapeutic enzyme developed for use against Acute Respiratory Distress Syndrome (ARDS). The move …

Pfizer World

Wyeth acquisition yet to shake Pfizer’s Lipitor dependence

February 4, 2010
Sales and Marketing 2009 financials, Lipitor, Pfizer

Pfizer’s profits rose by 7% last year on the back of a 4% increase in revenue driven by cholesterol treatment …

Fishawack makes US acquisition

February 4, 2010
Medical Communications Nexus Communications, fishawack

Cheshire-based healthcare agency Fishawack Communications has bought US outfit Nexus Communications. The company says this acquisition is part of a …

Oxford Immunotec appoints Frank Vandeputte

February 4, 2010
Sales and Marketing Oxford Immunotec, appointment, medical devices, sales and marketing

Medical diagnostics company Oxford Immunotec has appointed Frank Vandeputte vice president, sales and marketing. He was formerly VP, Europe for …

Eden Biodesign passes into Watson Pharma’s hands

February 4, 2010
Manufacturing and Production Eden Biodesign, Watson Pharma, biologicals

UK biologics manufacturing specialist Eden Biodesign has been bought by US drugmaker Watson Pharmaceuticals in a $15 million deal. The …

Lancet retracts MMR research conclusions

February 3, 2010
Research and Development MMR, Sanofi, vaccines

The Lancet, the journal which originally published the controversial research linking the MMR vaccine to autism has issued a full …

Digital Pharma: New EMA website previewed

February 3, 2010
Research and Development, Sales and Marketing EMA, branding, digital pharma

The European Medicines Agency is preparing to overhaul its website to make it easier for users to get information. This …

Digital added to PM’s as Langland clean up

February 3, 2010
Medical Communications Langland, awards, pm society

Langland swept the board at the PM Society’s Advertising Awards on 29 January with seven wins across 20 award categories. …

FDA to assess Neupogen biosimilar

February 3, 2010
Research and Development, Sales and Marketing Hospira, Teva, biosimilars

US regulator the FDA has agreed to assess Teva’s application for a biosimilar version of Amgen’s Neupogen (filgrastim). XM02, a …

Roche building

Genentech integration hits Roche profits

February 3, 2010
Sales and Marketing 2009 financials, Genentech, Roche

Roche achieved healthy sales growth in 2009 but saw a 22% drop in net income due to the cost gaining …

Talking Careers: The brief has changed

February 2, 2010
Business Services Talking Point, interim management, rsa, talking careers

Planning for the future is crucial at any time, but particularly when the market has changed and contracted as the …

Brennan maintains support for US reforms

February 2, 2010
Sales and Marketing Obama, US healthcare

David Brennan has reiterated the industry’s early support for President Obama’s healthcare plans, but acknowledged the recent election of a …

Parexel sees signs of recovery in Q2 figures

February 2, 2010
Research and Development CRO, Parexel

Contract research organisation Parexel International’s second-quarter net profit fell 34% to $3.5 million on restructuring and investment-impairment charges, but still …

Novo buoyed by insulin portfolio

February 2, 2010
Sales and Marketing 2009 financials, Novo Nordisk, Victoza

Danish pharma company Novo Nordisk managed a double-digit rise in sales and profits in 2009, buoyed by insulin products NovoRapid, …

Job cuts at GlaxoSmithKline and AstraZeneca

February 2, 2010
Research and Development, Sales and Marketing AstraZeneca, GlaxoSmithKline

Britain’s two biggest pharma companies GlaxoSmithKline and AstraZeneca are poised to make deep job cuts as business models continue to …

Servier fails to overturn NICE osteoporotic guidance

February 2, 2010
Sales and Marketing NICE, Servier, osteoporosis

Servier’s challenge to NICE guidance on preventing osteoporotic fractures has proved unsuccessful, with the watchdog’s original decision still standing. This …

ABPI appoints Amanda Stuart head of government affairs

February 2, 2010
Sales and Marketing ABPI, appointment, sales and marketing

Amanda Stuart will later this week join the ABPI as its new head of government affairs, with a remit to …

Lilly laboratory

Lilly signs diabetes deal with Alizé Pharma

February 2, 2010
Research and Development Alize, diabetes, lilly, type II

Lilly has signed a new research and licensing deal with Lyon-based Alizé Pharma to develop Alizé’s AZP-01 programme, focused on …

Contract research news in brief

February 2, 2010
Research and Development CRO, PRA, Quintiles

Our round-up of contract research news includes alliances for Quintiles and PRA International, a new CRO serving the Eastern European …

Sanofi-Aventis expands consumer health focus in China

February 1, 2010
Sales and Marketing China, Minsheng, Sanofi-Aventis, consumer healthcare, em

Sanofi-Aventis has partnered with China’s Minsheng Pharmaceuticals to establish a new consumer healthcare joint venture. Sanofi will take a majority …

The Gateway to Local Adoption Series

Latest content